The drug Trikafta has changed the lives of many Canadians living with cystic fibrosis. But in many other parts of the world, the drug is either not available — or if it is, it costs hundreds of thousands of dollars a year. That’s why Cheri Nel, who is based in Johannesburg, is suing American pharmaceutical company Vertex over its patent and price tag.
The internet of animals
Dermatologist shortage as skin cancer rates rise
ICC requests arrest warrants for Israeli, Hamas officials
Puck drops on first ever PWHL final
How gene editing could save endangered animals
Documentary: What Can a Widow Be?
Why birding is ‘quietly radical’
How farmers are adapting to extreme climate change
P.E.I. to reduce number of immigrant nominees for permanent residency
Cracking the problem of impaired driving
The great potato giveaway
Should Canada impose tariffs on Chinese EVs?
Wildfire evacuation is déjà vu for Fort McMurray
Why Alice Munro was a master of the short story
Alberta’s secretive water market
Finding out you have cancer — in the ER
Wildfire season has started. Here’s what to expect
WNBA coming to Canada
Decoding the sperm whale's alphabet
Strawberries with ketchup? Chefs turn to AI for new ideas
Create your
podcast in
minutes
It is Free
Front Burner
Vinyl Cafe
Ideas
Someone Knows Something
Under the Influence with Terry O’Reilly